Advertisements

Voltaren forte

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Voltaren forte

Quick Facts

Property Description
Active ingredient Diclofenac
Form Topical Emulgel / Gel
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common use Pain and Inflammation Relief
Origin Synthetic compound

Classification and Core Identity

Voltaren forte is a medicine classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID), whose active substance is the synthetic compound Diclofenac. This drug belongs to the anti-rheumatic and analgesic pharmacological class, primarily designed to manage discomfort associated with localized inflammation. As a proprietary product often positioned as an over-the-counter (OTC) option in many jurisdictions, Voltaren forte delivers a formulation that is clinically recognized for enhancing the localized therapeutic effect, compared to standard topical concentrations. This preparation is formulated exclusively as a specialized topical preparation, typically an emulgel, for cutaneous application, distinguishing its route from systemic NSAIDs.


Composition, Form, and General Purpose

This medicine is a single-ingredient product. The active substance is present as Diclofenac diethylamine, a salt form specifically optimized for absorption through the skin barrier, a development supported by pharmacological studies. This unique emulgel base is intended to ensure effective and targeted delivery of the Diclofenac into the underlying tissues. The general purpose of this topical formulation is to provide a dual action: targeted analgesic effect (relief from pain) and an anti-inflammatory effect. Diclofenac's action involves locally inhibiting the synthesis of prostaglandins, which are key chemical mediators responsible for triggering and sustaining inflammation. The conclusion drawn from its mechanism is that the medicine effectively works by neutralizing the chemical signals that cause pain and swelling at the site of application.

Regulatory References

  1. NIH MedlinePlus
Advertisements

What side effects are possible with Voltaren forte?

Official Safety Profile and Adverse Reactions

The safety profile of Voltaren forte, a topical preparation containing the nonsteroidal anti-inflammatory drug (NSAID) Diclofenac, is primarily characterized by effects localized to the application site, as low systemic absorption is generally expected. Adverse reactions are classified according to frequency, based on official regulatory documentation.

Classification Examples of Reactions (System Organ Class)
Common (1 to 10 users in 100) Skin and Subcutaneous Tissue Disorders (e.g., Dermatitis, Rash, Pruritus, Erythema)
Rare (1 to 10 users in 10,000) Bullous Dermatitis (blistering), Urticaria
Very Rare (Less than 1 user in 10,000) Immune System Disorders (e.g., Angioedema, Hypersensitivity), Respiratory Disorders (e.g., Asthma), Photosensitivity reactions, Gastrointestinal complaints

Safety Constraints and Considerations

Official labeling documents address specific constraints related to the potential for systemic exposure and the nature of the active ingredient. Serious adverse reactions such as severe hypersensitivity (Angioedema) and systemic Asthma onset are documented as very rare events.

Safety is influenced by the extent of use. The risk of systemic adverse reactions is explicitly documented to increase with the size of the skin surface treated and the duration of application. Furthermore, the potential for a Photosensitivity reaction is noted, requiring appropriate patient awareness regarding sun exposure during use.

Consistent with the NSAID class, the product is formally contraindicated in patients with known hypersensitivity to Diclofenac, aspirin, or other NSAIDs, and its use is prohibited during the third trimester of pregnancy.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The official overdose profile for Diclofenac (the active ingredient in Voltaren forte) is primarily concerned with the potential consequences of significant systemic exposure, such as accidental ingestion, as overdose is generally considered unlikely with correct topical use. The manifestations documented in government labeling reflect severe systemic NSAID toxicity.

Documented Overdose Presentations

System Documented Manifestations
Gastrointestinal Nausea, vomiting, diarrhea, abdominal pain, and gastrointestinal bleeding.
Neurological Headache, dizziness, drowsiness, confusion, agitation, and convulsions (seizures).

Required Emergency Actions

Acute Organ Toxicity: Severe systemic outcomes documented in regulatory sources include acute renal failure and hepatic damage (liver injury), which can be life-threatening.

Immediate Action: Regulatory authorities mandate that immediate medical attention must be sought if an overdose is suspected or confirmed. You must contact emergency services or a poison control center immediately. If a significant excess of the topical gel is applied, the excess should be removed and washed off with water.

Management Principle: Management involves symptomatic and supportive treatment because no specific antidote is known for Diclofenac toxicity. Hospital monitoring may be required. Overdose consequences may be more severe for patients with pre-existing renal or hepatic impairment.

Advertisements

Therapeutic Uses of Voltaren forte

Diclofenac, the active ingredient in Voltaren forte, is used in situations involving certain distressing symptoms, applying across domains where additional symptomatic support is needed. This medication is considered relevant for easing symptoms linked to organ-specific functional stress, such as in conditions presenting with systemic or localized discomfort, including osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

In these contexts, the use of Diclofenac supports patients during episodes of heightened discomfort by easing symptoms related to inflammatory or irritative states, such as swelling and joint pain. It is applied in addressing symptom clusters that may become intense or disruptive, which may assist with maintaining functional stability when symptoms interfere with routine activities. This assists with maintaining functional stability and helps ease the overall symptom load during periods of heightened symptoms.

Quick Fact: Relief for Symptoms related to physical discomfort

Advertisements

Eligibility and Restrictions for Use

Voltaren forte, a topical Nonsteroidal Anti-Inflammatory Drug (NSAID), is governed by strict regulatory eligibility rules that define who can use the medicine and who is prohibited.

Eligibility Scope

Category Official Regulatory Status
Populations for whom use is allowed Adults (18+ years) for labeled topical uses. Adolescents aged 14 years and over for certain formulations (varies by region).
Populations for whom use is contraindicated Individuals with a known hypersensitivity to diclofenac, aspirin, or any other NSAID. Patients with a history of NSAID-induced allergic reactions (e.g., asthma, urticaria). Patients undergoing coronary artery bypass graft (CABG) surgery.

Age- and Condition-Specific Rules

Category Regulatory Status (As Defined in Official Documents)
Age-related eligibility rules Use is not established in children under 14 years of age. Use in older adults (geriatric) is permitted but requires caution due to elevated systemic risk profiles.
Condition-specific eligibility rules Use should be avoided in patients with advanced renal disease or severe heart failure unless benefits outweigh risks. Caution is required with a history of gastrointestinal ulcers or bleeding.
Pregnancy and lactation eligibility Contraindicated for use in women starting at 30 weeks gestation (third trimester). Use during breastfeeding is not generally recommended, and the gel must not be applied to the breasts.

Connection to the overall eligibility profile:

Regulatory documentation defines who can and cannot use the medicine by establishing absolute prohibitions based on systemic NSAID risk (allergy, CABG, late pregnancy) and imposing conditional restrictions related to age, organ function, and the integrity of the application site. Eligibility is confined primarily to the adult population, with young children being explicitly deemed not established for use.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Voltaren forte (Topical Diclofenac) around pharmacokinetic and pharmacodynamic risks, in addition to specific administration constraints. Co-administration with oral Non-steroidal Anti-inflammatory Drugs (NSAIDs) is generally avoided due to the potential for additive adverse effects, specifically increased gastrointestinal and renal risks.

Pharmacodynamic Interactions

Interactions involving an increased additive effect on bodily systems are documented. Combining with Anticoagulants (such as Warfarin) or other medicines that interfere with hemostasis (e.g., SSRIs) carries an increased risk of serious bleeding. Topical diclofenac may also officially diminish the antihypertensive effect of co-administered ACE Inhibitors or Angiotensin Receptor Blockers and can reduce the natriuretic effect of Diuretics. Furthermore, the co-administration with Cyclosporine increases the documented risk of nephrotoxicity.

Exposure and Clearance Interactions

Interactions that alter plasma concentration or clearance are formally noted. The medicine can increase the plasma levels and reduce the renal clearance of substances like Lithium, Digoxin, and Methotrexate. Metabolic interaction warnings, based on the drug substance, note that strong CYP2C9 inhibitors may significantly increase diclofenac systemic exposure.

Administration Restrictions

The label mandates that co-administration with other topical products on the same skin site must be avoided. The application site should also not be covered with clothing or gloves for at least 10 minutes after application.

Advertisements

Mechanism of Action

How Voltaren forte Works

Targeting Inflammatory Enzymes

This mechanism begins at the molecular level with the drug acting as an inhibitor of specific Cyclooxygenase (COX) enzymes ( COX-1 and COX-2) . By binding to the active site of these enzymes, the drug interferes with the Arachidonic Acid Cascade by blocking a key enzymatic step that generates pro-inflammatory chemical messengers. This primary action prevents the synthesis of these mediators, which is a necessary step for the resulting physiological effects.


Modulating Nociception and Tissue Excitability

The result of the enzyme blockade is a reduction in the local concentration of prostaglandins and other related signaling molecules in peripheral tissues. These mediators are known to initiate changes in vascular permeability and contribute to localized cellular events. The ensuing decrease in their levels is one factor that influences the factors contributing to localized tissue edema and the alteration in the excitability of peripheral nerve endings (nociceptors). This mechanism contributes to the alteration in the transmission of afferent (sensory) signals from the affected area.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Diclofenac Topical Gel

This section outlines the standardized usage of Diclofenac topical gel, the active substance in Voltaren forte formulations.


Dosing and Administration

Usage Feature General Instructions
Route of Administration Exclusively cutaneous use (topical application) to the skin.
Dosing Principle The lowest effective dosage should be used for the shortest duration consistent with individual treatment goals.
Frequency (1% Gel) Applied 4 times daily to the affected area.
Frequency (2.32% Gel) Applied 2 times a day, typically morning and evening.

Standard Dosing and Limits

Diclofenac gel is measured by the amount in grams, which is determined by the size and location of the area being treated.

  • Upper Extremities (Hand, Wrist, Elbow, 1% Gel): 2 grams per joint per application, with a total maximum of 8 grams daily for any single joint.
  • Lower Extremities (Knee, Ankle, Foot, 1% Gel): 4 grams per joint per application, with a total maximum of 16 grams daily for any single joint.
  • The total daily dose across all affected joints must not exceed 32 grams per day.

Procedural Steps and Use Constraints

The proper amount of gel must be measured for each application, often using a dosing card supplied with the product. The gel should be gently rubbed into the skin. After application, hands must be washed immediately, unless the hands are the area being treated. The treatment duration is strictly short-term; use should not exceed a set period (e.g., 7 days or 21 days for specific indications) without medical re-evaluation. For adolescents aged 14 and over, use is generally limited to 7 days for pain relief.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence

Summary of Study Findings

The combined data summarizes the key findings of studies that explored the compound's profile. The research conducted has focused on the compound's effect profile, short-term investigation, and initial safety data. The primary area of study involves conditions characterized by inflammation and pain, such as specific forms of arthritis.

Clinical Trial Outcomes

1. Pain and Inflammation

Research explored whether the compound was associated with changes in pain scores over a defined short-term period. Studies evaluated the use of the compound in chronic inflammation:

  • Osteoarthritis (OA): A Phase 3 trial examined the effect of the compound on daily pain scores in patients with OA over a 12-week period. The trial also tracked patient-reported changes in mobility.
  • Rheumatoid Arthritis (RA): A randomized controlled trial (RCT) examined whether there was an observation of a change in joint swelling and tenderness compared to placebo. Secondary outcomes included patient-reported global assessment of disease activity.

2. Combination Therapy Research

Studies investigated whether the compound was associated with a change in the duration of flare-ups in patients with chronic pain conditions. Research into extended use examined the safety profile of the compound over prolonged periods, typically up to one year.

Safety and Tolerability Research

Safety studies focused on common adverse events and specific organ system impacts. The research methodology included specific guidelines for drug administration. The most frequently reported adverse events in studies were classified as gastrointestinal distress and headache. Studies specifically examined the potential for cardiovascular adverse events in patients with a history of heart conditions.

Key Studies & References

  1. Diclofenac sodium - FDA Verification Portal (Example of Regulatory Document/Product Information)
  2. Safety review of diclofenac - Therapeutic Goods Administration (TGA) (Cardiovascular Safety and Hepatotoxicity)
  3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) - StatPearls - NCBI Bookshelf
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Voltaren forte (FAQ)


Q: What is the main difference between Voltaren forte and regular Voltaren?

Official product information indicates that Voltaren forte is a higher concentration formulation of the active ingredient, diclofenac, compared to standard topical products. This difference in concentration is designed to provide an enhanced localized therapeutic effect at the site of application. The specific concentration may vary based on the regulatory approval for the formulation.


Q: Why is the word 'forte' used in the name of this medicine?

The term 'forte' is used in the brand name to signify a formulation that provides an enhanced localized therapeutic effect. This generally indicates that the product contains a higher concentration of the active ingredient, diclofenac, compared to standard topical concentrations.


Q: How long does it usually take for Voltaren forte to start working?

According to regulatory labeling, this topical gel is not intended for immediate pain relief. Official product information suggests that for chronic conditions like arthritis pain, it may take up to 7 days of use to see a noticeable change in symptoms, as the product is not designed for immediate effect.


Q: Can Voltaren forte be used for all types of body pain?

Official regulatory documents indicate that the product is not approved for all types of body pain. Specifically, its effectiveness has not been demonstrated for acute conditions like strains, sprains, bruises, or general sports injuries. The labeling indicates its use is for specific joint pain, such as that associated with osteoarthritis, and not for general pain management.


Q: Are there any known common stomach side effects with Voltaren forte?

Systemic gastrointestinal complaints, such as severe ulcers or bleeding, are documented as Very Rare events for the topical gel due to low absorption. However, clinical studies often classify general gastrointestinal distress as a frequently reported adverse event. The risk of stomach issues is generally lower compared to oral forms of the medicine.


Q: Is it okay to take Voltaren forte if I have high blood pressure?

Official documents indicate that the active ingredient, diclofenac (an NSAID), may be associated with increasing or worsening existing high blood pressure (hypertension). Official labeling states that the product is intended for use with caution in individuals with pre-existing hypertension or fluid retention.


Q: Are there any specific foods or drinks that interact with Voltaren forte?

The NSAID class of medicines is known to have potential interactions with alcohol/food/lifestyle factors. While the topical gel has low systemic absorption, official interaction data for the active ingredient notes this potential risk due to the small possibility of systemic absorption.


Q: Is it true that Voltaren forte should not be used if you have a history of ulcers?

Official labeling documents that caution is required for use by patients with a history of stomach ulcers or internal bleeding. This is due to the inherent NSAID-class warning regarding the potential for severe gastrointestinal bleeding.


Q: Can older people use Voltaren forte safely?

Use in older adults (geriatric population) is permitted according to eligibility rules. Official documents note that caution is advised for use by older adults because the body may process the drug more slowly, potentially leading to higher systemic exposure.


Q: Is Voltaren forte suitable for people who are physically active or athletes?

Official labeling specifies that the product is not indicated for acute muscle conditions like strains, sprains, bruises, or sports injuries. The intended use is for pain associated with specific joint conditions, such as osteoarthritis.


Q: Are there long-term health effects associated with Voltaren forte use?

Regulatory labeling notes that the risk of systemic side effects is documented to increase with the duration of application. Therefore, use is typically limited to a set period (e.g., 7 or 21 days), and extended use requires re-evaluation.


Q: Can I take Voltaren forte with common cold and flu medications?

Official documents address the need to avoid taking the medicine with other painkillers or fever reducers that may contain other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), such as aspirin or ibuprofen. Combining NSAIDs, often found in cold and flu remedies, increases the overall risk of side effects.


Q: What are the signs of an allergic reaction to Voltaren forte?

Official warnings detail the signs of a severe allergic reaction, which may include hives, wheezing (asthma), facial swelling, skin blistering, or shock. These events are documented as very rare. If any of these symptoms occur, the official guidance states that the product use should be stopped and medical help should be sought immediately.


Q: What happens if I accidentally take more Voltaren forte than intended?

If the gel is accidentally swallowed, official labeling recommends immediately seeking medical attention or contacting a Poison Control Center. Using more of the product, or using it for a longer duration than directed, also increases the risk of serious NSAID-related side effects.


Q: Does taking Voltaren forte require a prescription in all countries?

The product's status varies depending on the country and the specific concentration. While it may be available as a prescription drug in some areas, it is also widely positioned as an over-the-counter (OTC) option in many jurisdictions, often based on local regulatory rules.


Q: Is Voltaren forte known to cause dizziness or affect driving?

The active ingredient, diclofenac, is documented to rarely cause systemic effects such as dizziness or sleepiness. Official documents note that if a person experiences these effects, driving or operating machinery may be impaired, and caution is advised.


Q: Are there different strengths of Voltaren forte available?

The term Voltaren forte is commonly used for a specific, higher concentration topical diclofenac formulation (such as 2.32%) to distinguish it from standard concentrations (e.g., 1% gel). The active ingredient itself is manufactured in various strengths depending on the brand and regulatory approval.


Q: Can I take Voltaren forte if I am already taking herbal supplements?

Official safety information indicates that there is not enough information available to confirm the safety of taking herbal remedies, vitamins, or complementary supplements with the medicine. This is because these products are generally not subject to the same testing for drug interactions as prescribed or regulated medications.


Q: Can men and women use Voltaren forte for the same pain conditions?

Official use conditions for the treatment of pain associated with specific conditions are generally gender-neutral. The only gender-specific restrictions documented in regulatory information apply to women during the third trimester of pregnancy and while breastfeeding due to associated systemic risks.


Q: Is there any risk of becoming dependent on Voltaren forte?

The active ingredient, diclofenac, is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID) and is not a narcotic. Regulatory documents contain no warnings regarding the potential for physical dependence or addiction associated with the use of this topical medicine.


Q: How quickly is Voltaren forte eliminated from the body?

Studies related to the active ingredient, diclofenac, indicate a half-life of elimination typically in the range of 5 to 11 hours for systemic forms. The overall elimination profile for the topical gel will differ due to its method of application and lower systemic absorption into the bloodstream.


Q: What is the difference between Voltaren forte tablets and gel?

Voltaren forte is a topical gel applied directly to the skin, which results in localized action. This topical route leads to significantly lower systemic absorption of the active ingredient, meaning it is generally associated with fewer systemic side effects compared to oral (tablet) forms of diclofenac.


Q: Are there any reported interactions with common vitamins when taking Voltaren forte?

Official safety information indicates that there is not enough information available to confirm the safety of taking vitamins, herbal remedies, or complementary supplements with the medicine. This is because these products are generally not subject to the same testing for drug interactions as prescribed or regulated medications.


Q: Why is alcohol generally advised against while taking Voltaren forte?

Official interaction data includes a potential interaction with alcohol due to the NSAID class-effect, which carries risks such as gastrointestinal bleeding. While the topical form has low systemic absorption, this NSAID-class warning is documented.


Q: Is the 'forte' version always stronger than the non-forte version?

Official product descriptions define the 'forte' preparation as a formulation associated with enhancing the localized therapeutic effect. This enhancement is achieved through a higher concentration compared to standard topical products, though official documents avoid using the subjective term 'always stronger.'


Q: Does Voltaren forte have an effect on liver function?

The product carries a specific Liver warning in its labeling. This is because the active ingredient, diclofenac, has the potential to cause a rare but serious adverse reaction known as liver damage (hepatotoxicity), which is documented even with the topical formulation.


Q: What information should I read on the package insert before using Voltaren forte?

Regulatory labeling indicates that the Medication Guide (User Guide) and the Dosing Card supplied with the product should be reviewed before use. These documents contain complete instructions for application, as well as crucial safety warnings and necessary information about the medicine.


Q: Are there different brand names for the same medicine as Voltaren forte?

The active ingredient, diclofenac topical gel, is available under various generic names and several other brand names in different regions, including different concentrations of Voltaren formulations. These may include brands such as Solaraze, depending on the jurisdiction and intended use.


Q: Can Voltaren forte affect fertility in men or women?

As a Nonsteroidal Anti-Inflammatory Drug (NSAID), the active ingredient diclofenac belongs to a class of medicines associated with a potential effect on fertility in women. However, the risk is typically considered lower with the topical gel due to its low systemic absorption compared to oral forms.

Advertisements

How should Voltaren forte be stored and disposed of?

How to Store and Dispose of Voltaren forte

Storage of Voltaren forte (diclofenac diethylamine gel) must adhere strictly to regulatory guidelines to maintain its effectiveness and ensure safety.


Storage Conditions

The gel must not be stored above 30 C and must be protected from light. It is prohibited to freeze the product. For safety, the tube must always be kept out of the sight and reach of children.

Voltaren forte has a total shelf-life of 36 months, but its in-use stability is 24 months after first opening the container.

Special Handling and Disposal

Fabric (such as clothing or bedding) that has had the gel dried on it may present a fire hazard; therefore, do not smoke or go near naked flames during application.

Disposal of any unused or expired product must be done in accordance with local requirements. Medicines must not be disposed of via wastewater or household waste; consult a pharmacist for proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Voltaren forte found in:

A-Z Index: